Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
Clinical trial NCT02169557 · COMPLETED
Trial details
- NCT number
- NCT02169557
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-30
- Primary completion
- 2016-10-09
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.